Here, we systematically analyzed the molecular pathological features of ESR1-CCDC170 fusion-positive breast cancer through the data analysis of the Cancer Genome Atlas (TCGA) and identified the activated oncogenic pathways. The gene discussed is CCDC170; the disease is breast carcinoma.